Fusogenic porous silicon nanoparticles as a broad-spectrum immunotherapy against bacterial infections
DownloadAccepted version (1.313Mb)
Open Access Policy
Open Access Policy
Creative Commons Attribution-Noncommercial-Share Alike
Terms of use
Metadata
Show full item recordAbstract
<p>RNAi-mediated immunotherapy provided by fusogenic porous silicon nanoparticles demonstrates superior therapeutic efficacy against both Gram-positive and Gram-negative bacterial infections compared with first-line antibiotics.</p>
Date issued
2021-02Department
Koch Institute for Integrative Cancer Research at MITJournal
Nanoscale Horizons
Publisher
Royal Society of Chemistry (RSC)
Citation
Kim, Byungji, Yang, Qinglin, Chan, Leslie W, Bhatia, Sangeeta N, Ruoslahti, Erkki et al. 2021. "Fusogenic porous silicon nanoparticles as a broad-spectrum immunotherapy against bacterial infections." Nanoscale Horizons, 6 (4).
Version: Author's final manuscript
ISSN
2055-6756
2055-6764